sufentanil has been researched along with Breast Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Han, L; Hu, Z; Huang, S; Wang, Q; Wang, Y; Xu, F; Zhao, S; Zhou, R; Zhu, H | 1 |
1 other study(ies) available for sufentanil and Breast Diseases
| Article | Year |
|---|---|
Polymorphisms contribute to differences in the effect of rocuronium in Chinese patients.
Topics: Adult; Anesthesia, General; Asian People; Breast Diseases; Female; Genetic Variation; Genotype; Humans; Male; Middle Aged; Neuromuscular Nondepolarizing Agents; Polymorphism, Single Nucleotide; Propofol; Remifentanil; Rocuronium; Sufentanil; Thyroid Diseases; Time Factors | 2022 |